[1]
Muhammad Abdul Quddus, Rabia Tahir, Rukhsana Munawar, Rizwan Saeed Kiani, Nadia Qazi, and Tahira Jehangir, “Risk factor for Rifampicin, Isoniazid and Pyrazinamide induced Hepatitis in Pulmonary Tuberculosis patients”, Pak J Chest Med, vol. 28, no. 1, pp. 31–38, Mar. 2022.